The new drug, called LM11A-31, targets a specific receptor called P75NTR in the brain that helps regulate brain cell survival and development. When cells, or neurons, die, messages can't be passed ...

Preclinical studies show that modulating p75NTR with the first-in-class small chemical LM11A-31 reduces amyloid-induced and pathological tau-induced synapse loss. In the present randomized ...